Avantax Advisory Services, Inc. Illumina, Inc. Transaction History

Avantax Advisory Services, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	SELL	$193.75 - $232.55 $19,956 - $23,952	-103 Reduced 7.99%	1,186 $275,000
Q4 2022 Feb 13, 2023	SELL	$187.24 - $242.74 $13,668 - $17,720	-73 Reduced 5.36%	1,289 $260,000
Q3 2022 Nov 01, 2022	BUY	$177.23 - $227.44 $241,387 - $309,773	1,362 New	1,362 $260,000
Q2 2022 Aug 02, 2022	SELL	$181.58 - $368.0 $207,545 - $420,624	-1,143 Closed	0 $0
Q1 2022 Apr 27, 2022	SELL	$303.87 - $423.8 $12,154 - $16,952	-40 Reduced 3.38%	1,143 $397,000
Q4 2021 Jan 24, 2022	BUY	$347.28 - $421.83 $11,807 - $14,342	34 Added 2.96%	1,183 $450,000
Q3 2021 Oct 21, 2021	BUY	$405.61 - $524.84 $84,366 - $109,166	208 Added 22.1%	1,149 $466,000
Q2 2021 Jul 29, 2021	BUY	$372.84 - $481.5 $53,688 - $69,336	144 Added 18.07%	941 $444,000
Q1 2021 May 13, 2021	BUY	$361.28 - $504.76 $3,974 - $5,552	11 Added 1.4%	797 $307,000
Q4 2020 Jan 22, 2021	SELL	$292.7 - $370.96 $242,648 - $307,525	-829 Reduced 51.33%	786 $290,000
Q3 2020 Oct 14, 2020	BUY	$268.51 - $400.74 $171,040 - $255,271	637 Added 65.13%	1,615 $497,000
Q2 2020 Aug 06, 2020	BUY	$256.46 - $373.01 $250,817 - $364,803	978 New	978 $363,000

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Avantax Advisory Services, Inc. with notifications on news.